Nonplatinum-based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population-based Danish anal cancer group study.

Christina Glismand TruelsenEva Serup-HansenKatrine Smedegaard StormBirgitte Mayland HavelundCamilla Skovhus KronborgKaren-Lise Garm Spindler

Published in: Cancer medicine (2021)

This study recognizes Paclitaxel and Capecitabine as a potential regimen for advanced SCCA, when recommended first-line therapy is not feasible or as a potential second-line treatment after failure of platinum-based chemotherapy.

Keyphrases

squamous cell
high grade
locally advanced
phase ii study
metastatic breast cancer
randomized controlled trial
metastatic colorectal cancer
chemotherapy induced
bone marrow
mesenchymal stem cells
combination therapy
cell therapy
replacement therapy
open label